Trial NCT04690855

View at ClinicalTrials.gov 
Org. Study IDs: HCRN BRE19-433

Last trial update was posted on 2023-12-04

MeSH Interventions

Atezolizumab Talazoparib

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Breast Cancer Triple Negative Breast Cancer

Stopping Reasons

This study has been terminated due to Lack of Accrual.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID